Phase I/II clinical safety studies of terameprocol vaginal ointment

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

JoAnn Suzich, S. Ghim, Frances J. Palmer‐Hill et al. · Proceedings of the National Academy of Sciences · 1995 · 671 citations

Life Sciences, Immunology, Infectious Diseases +17

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Evan R. Myers, Douglas C McCrory, Kavita Nanda et al. · American Journal of Epidemiology · 2000 · 480 citations · Full text

Medicine, Oncology, Pathology +17

Regression of low-grade squamous intra-epithelial lesions in young women

Anna‐Barbara Moscicki, Stephen Shiboski, Nancy K. Hills et al. · The Lancet · 2004 · 452 citations

Medicine, Gynecology, Obstetrics +13

Treatment for Cervical Intraepithelial Neoplasia and Risk of Preterm Delivery

Lynn Sadler · JAMA · 2004 · 392 citations

Medicine, Gynecology, Obstetrics +16

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs

Graham Lappin, W. Kuhnz, R. Jochemsen et al. · Clinical Pharmacology & Therapeutics · 2006 · 242 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13